Founded in 1998, The Lustgarten Foundation supports research to find a cure for pancreatic cancer, facilitates dialogue within the medical and scientific community, and educates the public about the disease.
Today, The Lustgarten Foundation is America’s largest private foundation dedicated to funding pancreatic cancer research. Since its inception, the Foundation has directed more than $110 million to more than 200 research projects at nearly 60 medical and research centers worldwide. The Foundation has assembled the best scientific minds with the hope that one day early diagnosis will require nothing more than a routine blood test, and that better treatments can be found, someday leading to a cure. And because Cablevision underwrites The Lustgarten Foundation’s administrative costs, 100 percent of every dollar donated to the Foundation goes directly to this important research.
Pancreatic cancer is swift and silent, often undetected until it's too late. More than 41,000 people will die from it this year. The overall five-year survival rate for pancreatic cancer is eight percent and most with advanced cancer die within a year. There are no early detection tests, no effective long-term treatments and, unless the cancer is surgically removed in its earliest stages, no cure.
The Lustgarten Foundation is committed to changing these facts, and as a result of research funded by the Foundation:
- The genetic makeup of this cancer is better known today than ever before.
- Research to identify and develop new therapies is now underway.
- Early detection tests are being developed.
- Immunotherapies are being tested for treating pancreatic cancer.
- More clinical trials are available for pancreatic cancer.
- Families are being examined to determine which genes cause hereditary pancreatic cancer.
With only two percent of federal funding directed at researching the nation's fourth-leading cause of cancer deaths, The Lustgarten Foundation's efforts have led to a substantially better understanding of pancreatic cancer and to successfully advancing research to find a cure.